Article
Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells
15 Oct 2018
Abstract excerpt
Resistance to chemotherapy remains a significant problem in the treatment of breast cancer, especially for triple-negative breast cancer (TNBC), in which standard systemic therapy is currently limited to chemotherapeutic agents. Our study aimed to better understand the molecular mechanisms that lead to failure of chemotherapy in TNBC. Herein, we observed elevated expression of Notch1 and major vault protein (MVP)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
